Form 4 for IMVT Immunovant, Inc.
Accepted 2026-08-28 16:27:50 ET · period of report 2026-08-28 · accession 0001764013-26-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Pande Atul | Dir | S - Sale+OE | $43.27 | -1,500 | 116.7K | -1% | -$64.9K |
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Pande Atul | Dir | M - OptEx | $0.00 | -1,500 | 65.2K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | M | A | 1,500 | $8.43 | 118,231 | D | — | — | (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. |
| 2 | Common | Common Stock | 2026-08-28 | S | D | 1,500 | $43.27 | 116,731 | D | — | — | (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. |
| 3 | Derivative | Stock Option (right to buy) | 2026-08-28 | M | D | 1,500 | $0.00 | 65,181 | D | $8.43 · — to 2029-11-19 | 1,500 Common Stock | (F1) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025. (F2) Reflects an award of stock options to purchase Common Shares that is fully vested. |